Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Wolfert

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Urology|May 1, 1999
Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastasesM F Darson, A Pacelli, P Roche, et al.
The Prostate|October 8, 1997
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancerG P Murphy, M J Troychak, O E Cobb, et al.
Urology|November 24, 1999
Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysisA W Partin, W J Catalona, J A Finlay, et al.
Urology|June 4, 1998
Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancerG P Murphy, G M Kenny, H Ragde, et al.
Cancer|August 15, 1996
Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigenG P Murphy, R J Barren, S J Erickson, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Urology|May 1, 1999
Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastasesM F Darson, A Pacelli, P Roche, et al.
The Prostate|October 8, 1997
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancerG P Murphy, M J Troychak, O E Cobb, et al.
Urology|November 24, 1999
Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysisA W Partin, W J Catalona, J A Finlay, et al.
Urology|June 4, 1998
Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancerG P Murphy, G M Kenny, H Ragde, et al.
Cancer|August 15, 1996
Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigenG P Murphy, R J Barren, S J Erickson, et al.
Pageof 4